A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
Recruiting in Palo Alto (17 mi)
+20 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Journey Medical Corporation
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
Research Team
LM
Lynne M Deans, MT
Principal Investigator
Dermira, Inc.
Eligibility Criteria
Inclusion Criteria
Male or female, 18 years of age or older.
Primary, axillary hyperhidrosis of at least 6 months duration.
A Hyperhidrosis Disease Severity Score (HDSS) of 3or 4.
See 2 more
Treatment Details
Interventions
- Glycopyrrolate (Anticholinergic)
Participant Groups
5Treatment groups
Experimental Treatment
Placebo Group
Group I: glycopyrrolate, 4.0%Experimental Treatment1 Intervention
glycopyrrolate Topical Wipes, 4.0%
Group II: glycopyrrolate, 3.0%Experimental Treatment1 Intervention
glycopyrrolate Topical Wipes, 3.0%
Group III: glycopyrrolate, 2.0%Experimental Treatment1 Intervention
glycopyrrolate Topical Wipes, 2.0%
Group IV: glycopyrrolate, 1.0%Experimental Treatment1 Intervention
glycopyrrolate Topical Wipes, 1.0%
Group V: VehiclePlacebo Group1 Intervention
Vehicle Topical Wipes
Find a Clinic Near You
Who Is Running the Clinical Trial?
Journey Medical Corporation
Lead Sponsor
Trials
10
Recruited
2,400+